JP2004530731A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004530731A5 JP2004530731A5 JP2003510034A JP2003510034A JP2004530731A5 JP 2004530731 A5 JP2004530731 A5 JP 2004530731A5 JP 2003510034 A JP2003510034 A JP 2003510034A JP 2003510034 A JP2003510034 A JP 2003510034A JP 2004530731 A5 JP2004530731 A5 JP 2004530731A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10134775A DE10134775A1 (de) | 2001-07-06 | 2001-07-06 | 1-Alkyl-2.aryl-benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate |
| PCT/EP2002/007597 WO2003004023A1 (de) | 2001-07-06 | 2002-07-06 | 1-alkyl-2-aryl-benzimidazolderivate, deren verwendung zur herstellung von arzneimitteln sowie diese derivate enthaltende pharmazeutische präparate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004530731A JP2004530731A (ja) | 2004-10-07 |
| JP2004530731A5 true JP2004530731A5 (enExample) | 2009-10-01 |
Family
ID=7692119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003510034A Pending JP2004530731A (ja) | 2001-07-06 | 2002-07-06 | １−アルキル−２−アリール−ベンズイミダゾール誘導体、医薬製剤の製造のためへのそれらの使用、及びそれらの誘導体を含む医薬製剤 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1404321A1 (enExample) |
| JP (1) | JP2004530731A (enExample) |
| DE (1) | DE10134775A1 (enExample) |
| WO (1) | WO2003004023A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10207843A1 (de) * | 2002-02-15 | 2003-09-04 | Schering Ag | Mikrolia-Inhibitoren zur Unterbrechung von Interleukin 12 und IFN-gamma vermittelten Immunreaktionen |
| BRPI0313763B8 (pt) * | 2002-08-19 | 2021-05-25 | 4325231 Canada Inc | imidazóis 2,4,5-trissubstituídos, seus usos, e composições farmacêutica e anti-microbiana |
| AU2003301436A1 (en) | 2002-10-17 | 2004-05-04 | Amgen Inc. | Benzimidazole derivatives and their use as vanilloid receptor ligands |
| DK1692113T3 (en) | 2003-11-14 | 2018-01-08 | Lorus Therapeutics Inc | ARYLIMIDAZOLES AND USE THEREOF AS ANTICANCES |
| DE102004026590A1 (de) * | 2004-06-01 | 2006-01-12 | Siemens Ag | Assistenzsystem für Kraftfahrzeuge |
| US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7538113B2 (en) | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7582634B2 (en) | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| CN101248072B (zh) | 2005-05-25 | 2013-01-23 | 劳洛斯治疗公司 | 2-吲哚基咪唑并[4,5-d]菲咯啉衍生物及其在癌症治疗中的用途 |
| US7582636B2 (en) | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
| EP2350032B1 (en) | 2008-09-26 | 2016-05-25 | Eisai R&D Management Co., Ltd. | Benzoxazole compounds and methods of use |
| BRPI0919816A2 (pt) * | 2008-09-26 | 2019-09-24 | Eisai R&D Man Co Ltd | uso compostos benzoxazólicos no tratamento de malária |
| EP2501696B1 (en) * | 2009-10-15 | 2016-12-28 | Guerbet | Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases |
| WO2014153464A2 (en) | 2013-03-20 | 2014-09-25 | Lorus Therapeutics Inc. | 2-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| CN105764511B (zh) | 2013-10-04 | 2019-01-11 | 艾普托斯生物科学公司 | 用于治疗癌症的组合物和方法 |
| EP3390367B1 (en) * | 2015-12-15 | 2020-09-09 | The Board of Trustees of the Leland Stanford Junior University | Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation |
| CN111417395A (zh) | 2017-10-30 | 2020-07-14 | 艾普托斯生物科学公司 | 用于治疗癌症的芳基咪唑 |
| MX2021001456A (es) * | 2018-08-06 | 2021-05-27 | Univ Leland Stanford Junior | 2-arilbenzimidazoles como activadores de ppargc1a para tratar enfermedades neurodegenerativas. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4330959A1 (de) * | 1993-09-09 | 1995-03-16 | Schering Ag | Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
| US5552426A (en) * | 1994-04-29 | 1996-09-03 | Eli Lilly And Company | Methods for treating a physiological disorder associated with β-amyloid peptide |
| NZ519326A (en) * | 2000-01-14 | 2005-02-25 | Schering Ag | 1,2-diarylbenzimidazoles for treating diseases that are associated with a microglia activation |
-
2001
- 2001-07-06 DE DE10134775A patent/DE10134775A1/de not_active Ceased
-
2002
- 2002-07-06 EP EP02762333A patent/EP1404321A1/de not_active Withdrawn
- 2002-07-06 JP JP2003510034A patent/JP2004530731A/ja active Pending
- 2002-07-06 WO PCT/EP2002/007597 patent/WO2003004023A1/de not_active Ceased